Pharmafile Logo
Pharmafocus logo
Advanced Search

Edinburgh BioQuarter appoints commercialisation director

March 16, 2010
Research and Development Edinburgh BioQuarter, appointment, research and development

Dr Michael Capaldi has joined Scottish life sciences research hub Edinburgh BioQuarter as director of commercialisation. He will lead a …

Appointment

CME Spotlight: The numbers game

March 16, 2010
Medical Communications CME, CME Spotlight

We live in a world where people seem to have developed a strange obsession with numbers.I am still baffled at …

Feature

Revolade gets European go ahead

March 15, 2010
Sales and Marketing GlaxoSmithKline, Revolade, thrombocytopenia

European regulators have approved GlaxoSmithKline’s Revolade to treat reduced platelet count in patients with a rare blood disorder. Revolade (eltrombopag) …

News

FDA strengthens Plavix safety warning

March 15, 2010
Sales and Marketing Plavix

A boxed warning has been added to the US packaging of Sanofi-Aventis and Bristol-Myers Squibb’s blockbuster anti-clotting drug Plavix. The …

News
GSKstephenne

GSK promotes Jean Stephenne to chairman, biologicals

March 15, 2010
Research and Development, Sales and Marketing GlaxoSmithKline, appointment, research and development, sales and marketing

GlaxoSmithKline has appointed Jean Stephenne chairman of GSK Biologicals, the company’s global vaccines division.He is currently president and general manager of …

Appointment

Contract research news in brief

March 15, 2010
Research and Development Bilcare, CRO, Kendle, Lonza, Medidata, Melbourn, Quintiles, RDNIB

Our round-up of developments in the contract research sector includes updates from Kendle, Bilcare, Quintiles, Melbourn Scientific, Lonza, and Medidata …

News

Paul Holmes rejoins PM Society

March 12, 2010
Medical Communications PM Soc, appointment, medical communications, pm society

The Pharmaceutical Marketing Society has appointed Paul Holmes business development director. He will also rejoin the Society as a committee …

Appointment

Pfizer suffers late-stage cancer drug failures

March 12, 2010
Research and Development Cancer, Pfizer, Sutent, figitumumab

Pfizer has suffered late-stage trial failures for Sutent and lung cancer candidate figitumumab. Kidney cancer drug Sutent (sunitinib) failed to …

News
Richard Shore

Talking Point: Following transit and storage rules

March 12, 2010
Manufacturing and Production NYK Logistics, Talking Point, logistics, supply chain, talking logistics

Most people involved in pharmaceuticals will be aware of the strict procedures that must be employed for product manufacture (Good …

Feature

GSK expands inflammatory alliance

March 12, 2010
Research and Development Cellzome, GlaxoSmithKline, rheumatoid arthritis

GlaxoSmithKline has formed a second strategic alliance with Cellzome to research new treatments for inflammatory diseases. GSK will buy into …

News

Chinese API supplier warned by FDA over manipulated data

March 12, 2010
Manufacturing and Production API, China, XiAn Libang Pharmaceutical, manufacturing quality

A Chinese manufacturer has been sent a warning letter by the US Food and Drug Administration after it emerged an …

News

NHS urged to make more of new patient experience data

March 12, 2010
NHS, PROMs, hc, king's fund

Healthcare bosses and clinicians have been urged to make the most of new patient experience data. ‘Getting the most out …

News

AstraZeneca signs generics deal with Torrent

March 11, 2010
AZ, generics

AstraZeneca have signed a license and supply agreement with Indian-based Torrent Pharma that will boost its generics portfolio. Torrent will …

News
Ratiopharm HQ

Pfizer muscles in on Ratiopharm sale

March 11, 2010
Sales and Marketing Pfizer, Ratiopharm, Teva, generics

Pfizer has reportedly bid $4 billion for German generics firm Ratiopharm in a bid to rapidly expands its portfolio in …

News

Teva appoints Dr Phillip Frost chairman

March 11, 2010
Sales and Marketing Teva, appointment, sales and marketing

Teva Pharmaceutical Industries has appointed Dr Phillip Frost as chairman of the board of directors. His appointment is part of …

Appointment

Novartis buys into Transgene’s lung cancer candidate

March 11, 2010
Research and Development Novartis, Transgene, immunotherapy, lung cancer

French biotech company Transgene has signed a deal with Novartis for the future development and marketing of its potential lung …

News

Investments boost Irish pharma sector

March 11, 2010
Research and Development, Sales and Marketing Ireland, PPD, Warner Chilcott

Contract research organisation PPD has officially opened its new research laboratory in Athlone, Ireland, and started recruiting for the first …

News

German Health Minister attacks ‘pharma monopoly’

March 10, 2010
Sales and Marketing Germany, cost-effectiveness, price cuts, prices

German Health Minister Philipp Rösler wants to break pharma’s ‘monopolistic hold’ over the country by introducing price limits on new …

News

Five-year cardiovascular study planned for Onglyza

March 10, 2010
Research and Development, Sales and Marketing DPP-4, Onglyza, diabetes

Bristol-Myers Squibb and AstraZeneca are to embark on a five-year study of Onglyza in type II diabetes patients who may …

News

Abbott boosts pipeline with biotech acquisition

March 10, 2010
Research and Development, Sales and Marketing Abbott, Facet Biotech, daclizumab, volociximab

Abbott is to acquire US company Facet Biotech in a $450 million deal that will boost its oncology and immunology …

News
The Gateway to Local Adoption Series

Latest content

Alto Neuroscience announces new patent for depression treatment

January 15, 2026

Arkin Capital closes $100m fund for pre-clinical and early clinical-stage biotech

January 15, 2026

Bio-Sourcing and Zerion Pharma receive 1.3m euros in funding for joint breast cancer project

January 14, 2026

Biocartis announces breast cancer research collaboration with US Mayo Clinic

January 14, 2026

Blue Earth announces first UK patient received prostate cancer injection

January 13, 2026